
The difference in cardiovascular events between prostate cancer agonists and antagonists
In this video, international speaker Prof Axel Merseburger, together with local urologist A/Prof Matthew Roberts, compare cardiovascular events of agonists and antagonists in the treatment of prostate cancer.



Eligard® - Prostate Cancer

Job Code :
Dr Axel Merseburger
Chairman of the Department of Urology at the University Hospital Schleswig-Holstein in Lübeck, Germany